Publication | Closed Access

The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist

Drug SafetyClinical SafetyDrug Systematic ReviewsPatient SafetyDrug MonitoringPharmacotherapyPharmacovigilanceResearch EthicsPrisma HarmsMedicineAdverse Drug ReactionPharmacoepidemiology